Hospital Infection Therapeutics Market Development & Industry Challenges Report to 2019

About This Presentation
Title:

Hospital Infection Therapeutics Market Development & Industry Challenges Report to 2019

Description:

The report covers the present scenario and growth prospects of the global hospital infection therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of drugs used in the treatment of various hospital-acquired infections such as bloodstream infections, Clostridium difficile infections, hospital-acquired pneumonia, surgical site infections, and urinary tract infections. – PowerPoint PPT presentation

Number of Views:6

less

Transcript and Presenter's Notes

Title: Hospital Infection Therapeutics Market Development & Industry Challenges Report to 2019


1
Global Hospital Infection Therapeutics Market
2015-2019


Single User
License US 2500 No of Pages 83

Corporate User
License US 4000
  • www.rnrmarketresearch.com

WEBSITE
2
Global Hospital Infection Therapeutics Market
2015-2019
  • Global hospital infection therapeutics market to
    grow at a CAGR of 3.24 over the period
    2014-2019. Hospital-acquired diseases are also
    known as nosocomial infections that are acquired
    in hospitals and other healthcare facilities.
    These infections are classified only when a
    patient is admitted for reasons other than the
    infections and are caused by bacteria, fungi,
    parasites, or viruses. Most common types of
    hospital-acquired infections are SSIs, UTIs,
    bloodstream infections, pneumococcal infections,
    MRSA, and gastrointestinal illnesses. These
    infections appear between 48 hours and four days
    after a patient is admitted and are usually
    related to a treatment of procedure used to treat
    or diagnose the patient's initial illness or
    injury. Hospital-acquired diseases are
    preventable through adherence to strict
    guidelines and less usage of invasive equipment
    that must be followed by healthcare professionals
    while caring for the patient. Anti-infective
    drugs are used for the treatment of these
    infections. These infections can be minimized by
    following proper infection control measures in
    the hospitals and healthcare institutions.
  • View Complete Report _at_ http//www.rnrmarketresearc
    h.com/global-hospital-infection-therapeutics-marke
    t-2015-2019-market-report.html

3
Global Hospital Infection Therapeutics Market
2015-2019
  • The report covers the present scenario and growth
    prospects of the global hospital infection
    therapeutics market for the period 2015-2019. To
    calculate the market size, the report considers
    revenue generated from the sales of drugs used in
    the treatment of various hospital-acquired
    infections such as bloodstream infections,
    Clostridium difficile infections,
    hospital-acquired pneumonia, surgical site
    infections, and urinary tract infections.
  • The report, Global Hospital Infection
    Therapeutics Market 2015-2019, has been prepared
    based on an in-depth market analysis with inputs
    from industry experts. The report covers the
    Americas, APAC, and EMEA it also covers the
    landscape of the global hospital infection
    therapeutics market and its growth prospects in
    the coming years. The report includes a
    discussion of the key vendors operating in this
    market.
  • Purchase a Copy of this Report _at_
    http//www.rnrmarketresearch.com/contacts/purchase
    ?rname425597

4
Global Hospital Infection Therapeutics Market
2015-2019
  • Key regions Americas, APAC, EMEA
  • Key vendors Allergan, Bayer, GlaxoSmithKline,
    Merck, Pfizer
  • Other prominent vendors Abbott Laboratories,
    Achaogen, AmpliPhi Biosciences, Angelini Pharma,
    Aridis Pharmaceuticals, AstraZeneca, Durata
    Therapeutics, F. Hoffmann-La Roche, Isis
    Pharmaceuticals, Johnson Johnson, Ligand
    Pharmaceuticals, Massachusetts Biological
    Laboratories, Medarex, Meiji Seika Pharma,
    Melinta Therapeutics, Nektar, Novartis,
    Prokarium, Sanofi, Tetraphase Pharmaceuticals,
    The Medicines Company, Valneva,
  • Key market driver Development of multidrug
    resistant variants
  • Key market challenge Rise in number of
    infection control programs
  • Key market trend Patient assistance programs
  • Inquire on the Report at _at_ http//www.rnrmarketres
    earch.com/contacts/inquire-before-buying?rname425
    597

5
Global Hospital Infection Therapeutics Market
2015-2019
  • Key questions answered in this report
  • What will the market size be in 2019 and what
    will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats
    faced by the key vendors?
  • What are the strengths and weaknesses of the key
    vendors?
  • Inquire for Discount _at_ http//www.rnrmarketresearc
    h.com/contacts/discount?rname425597

6
RnR Market ResearchRnRMarketResearch.com, An
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RNR market research library has
syndicated reports by leading market research 
publishers across the globe. For more details
contact sales_at_rnrmarketresearch.Com /
18883915441FOLLOW US
Website
www.rnrmarketresearch.com
Write a Comment
User Comments (0)